Shandong Hualu-Hengsheng Chemical Co., Ltd. (SHA:600426)
China · Delayed Price · Currency is CNY 38.56
+0.40 (1.05%)
Apr 13, 2026, 3:00 PM CST
SHA:600426 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 30,600 | 33,795 | 26,924 | 29,347 | 26,425 |
Other Revenue | 369.11 | 431.08 | 336.31 | 898.18 | 318.95 |
| 30,969 | 34,226 | 27,260 | 30,245 | 26,744 | |
Revenue Growth (YoY) | -9.52% | 25.55% | -9.87% | 13.09% | 103.92% |
Cost of Revenue | 25,069 | 27,854 | 21,617 | 21,506 | 17,326 |
Gross Profit | 5,900 | 6,372 | 5,642 | 8,739 | 9,418 |
Selling, General & Admin | 396.98 | 418.59 | 387.23 | 307.78 | 326.16 |
Research & Development | 885.79 | 660.66 | 578.38 | 610.63 | 368.44 |
Other Operating Expenses | 91.1 | 39.06 | 187.64 | 215.64 | 134.01 |
Operating Expenses | 1,393 | 1,144 | 1,154 | 1,132 | 832.01 |
Operating Income | 4,507 | 5,228 | 4,488 | 7,607 | 8,586 |
Interest Expense | -276.52 | -258.72 | -97.77 | -91.08 | -109.6 |
Interest & Investment Income | 13.1 | 22.81 | 35.92 | 72.5 | 50.14 |
Currency Exchange Gain (Loss) | 5.37 | 19.36 | 6.62 | 0.43 | -4.11 |
Other Non Operating Income (Expenses) | -5.07 | -3.79 | -4.58 | -2.22 | -2.94 |
EBT Excluding Unusual Items | 4,244 | 5,008 | 4,428 | 7,587 | 8,520 |
Gain (Loss) on Sale of Investments | -19.66 | -32.03 | -6.39 | 1.23 | 1.02 |
Gain (Loss) on Sale of Assets | 1.79 | 4.52 | 5.21 | 16.54 | 15.4 |
Asset Writedown | - | - | - | -17.08 | - |
Other Unusual Items | 36.47 | 34.42 | -146.27 | -177.14 | 7.37 |
Pretax Income | 4,262 | 5,015 | 4,281 | 7,411 | 8,543 |
Income Tax Expense | 606.72 | 836.44 | 658.35 | 1,123 | 1,273 |
Earnings From Continuing Operations | 3,656 | 4,178 | 3,622 | 6,288 | 7,270 |
Minority Interest in Earnings | -340.15 | -275.61 | -46.53 | 1.85 | 0.45 |
Net Income | 3,315 | 3,903 | 3,576 | 6,289 | 7,271 |
Net Income to Common | 3,315 | 3,903 | 3,576 | 6,289 | 7,271 |
Net Income Growth | -15.04% | 9.14% | -43.14% | -13.50% | 304.30% |
Shares Outstanding (Basic) | 2,121 | 2,120 | 2,117 | 2,121 | 2,114 |
Shares Outstanding (Diluted) | 2,121 | 2,120 | 2,117 | 2,121 | 2,114 |
Shares Change (YoY) | 0.07% | 0.13% | -0.19% | 0.33% | -0.07% |
EPS (Basic) | 1.56 | 1.84 | 1.69 | 2.96 | 3.44 |
EPS (Diluted) | 1.56 | 1.84 | 1.69 | 2.96 | 3.44 |
EPS Growth | -15.10% | 9.00% | -43.04% | -13.78% | 304.59% |
Free Cash Flow | 547.56 | -112.6 | -3,995 | 29.33 | 1,233 |
Free Cash Flow Per Share | 0.26 | -0.05 | -1.89 | 0.01 | 0.58 |
Dividend Per Share | 0.500 | 0.600 | 0.600 | 0.800 | 0.800 |
Dividend Growth | -16.67% | - | -25.00% | - | 246.62% |
Gross Margin | 19.05% | 18.62% | 20.70% | 28.89% | 35.22% |
Operating Margin | 14.55% | 15.28% | 16.46% | 25.15% | 32.10% |
Profit Margin | 10.71% | 11.40% | 13.12% | 20.79% | 27.19% |
Free Cash Flow Margin | 1.77% | -0.33% | -14.66% | 0.10% | 4.61% |
EBITDA | 7,678 | 7,976 | 6,377 | 9,371 | 9,994 |
EBITDA Margin | 24.79% | 23.30% | 23.39% | 30.98% | 37.37% |
D&A For EBITDA | 3,171 | 2,748 | 1,889 | 1,764 | 1,408 |
EBIT | 4,507 | 5,228 | 4,488 | 7,607 | 8,586 |
EBIT Margin | 14.55% | 15.28% | 16.46% | 25.15% | 32.10% |
Effective Tax Rate | 14.23% | 16.68% | 15.38% | 15.15% | 14.90% |
Revenue as Reported | 30,969 | 34,226 | 27,260 | 30,245 | 26,744 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.